Top 10 Companies in the DHA Algae Oil Microcapsule Powder Market (2026): Market Leaders Powering Global Nutrition

MARKET INSIGHTS

Global DHA Algae Oil Microcapsule Powder Market was valued at USD 591 million in 2025. The market will grow from USD 630 million in 2026 to USD 922 million by 2034, registering a compound annual growth rate of 6.7% during the forecast period.

DHA algae oil microcapsule powder is a specialized spray‑dried, microencapsulated form of docosahexaenoic acid (DHA)‑rich oil derived from microalgae, primarily Schizochytrium sp. This advanced ingredient technology converts liquid algal oil into a stable, free‑flowing, and water‑dispersible powder, making it suitable for dry‑mix formulations and significantly extending its shelf life by protecting the sensitive DHA from oxidation. The DHA content in these powders typically ranges from approximately 10% to over 20%, depending on the encapsulation efficiency and the purity of the starting algal oil.

The market growth is primarily driven by the rising demand in infant formula and maternal nutrition, where the powder’s stability, odor‑masking properties, and plant‑based origin are highly valued. Furthermore, the expansion of the functional food and beverage sector, including solid beverages, meal replacements, and baked goods, is creating new avenues for growth as manufacturers seek stable, easy‑to‑use DHA formats. The industry, however, faces challenges related to cost pressures and the need for high‑quality encapsulation to ensure product stability and performance, which differentiates leading suppliers in a competitive landscape.

DHA Algae Oil Microcapsule Powder Market – View in Detailed Research Report

1. DSM‑Firmenich

Headquarters: Basel, Switzerland

Key Offering: High‑purity DHA microcapsule powder (10‑20% DHA) for infant formula and functional foods.

DSM‑Firmenich leverages its long‑standing expertise in nutritional lipids to deliver a product that meets the stringent purity and stability standards demanded by infant nutrition manufacturers. The company’s proprietary microencapsulation process reduces surface oil content, ensuring minimal flavor impact and extended shelf life in dry‑mix applications.

Sustainability & Growth Initiatives: The firm is committed to circular bio‑economy principles, sourcing algae from renewable bioreactors and employing energy‑efficient spray‑drying technology. It has set a target to reduce carbon intensity of its DHA production by 25% over the next five years.

• Investment in algae cultivation facilities in Europe and Asia.
• Partnerships with infant formula OEMs to co‑develop low‑cost, high‑value DHA blends.
• Data‑driven formulation support for precise dosing and reduced downstream losses.

2. Cabio

Headquarters: Shanghai, China

Key Offering: 10‑20% DHA microcapsule powder tailored for infant formula and nutritional supplements.

Cabio focuses on cost‑effective production while maintaining high encapsulation efficiency. Its scalable bioreactor platform allows rapid response to market demand in the Asia‑Pacific region.

Sustainability & Growth Initiatives: Cabio employs a closed‑loop water recycling system in its extraction units and has launched a certification program for traceable algae sourcing.

• Expansion of production capacity to 150 tpa by 2028.
• Collaboration with local universities on algae strain improvement.
• Launch of a digital tool for suppliers to monitor product quality in real time.

3. INNOBIO

Headquarters: Beijing, China

Key Offering: Premium DHA microcapsule powder (10‑20% DHA) for infant nutrition and functional foods.

INNOBIO’s advanced multilayer encapsulation technology delivers superior flavor masking and oxidative stability, positioning it as a preferred supplier for premium infant formula brands.

Sustainability & Growth Initiatives: The company has committed to zero‑waste operations and is piloting algae cultivation on municipal wastewater streams.

• Strategic partnership with a leading global infant formula manufacturer.
• Investment in AI‑driven process optimization to reduce energy consumption.
• Launch of a sustainability reporting framework aligned with GRI standards.

4. Nu‑Mega Ingredients

Headquarters: Sydney, Australia

Key Offering: 10‑20% DHA microcapsule powder for functional foods, beverages, and dietary supplements.

Nu‑Mega’s focus on regional distribution in Oceania and the Asia‑Pacific allows it to offer rapid delivery and localized product development.

Sustainability & Growth Initiatives: The firm is integrating renewable energy sources into its production plants and has achieved ISO 14001 certification.

• Expansion of product portfolio to include heat‑stable DHA blends for baked goods.
• Collaboration with local dairy brands to fortify plant‑based milk alternatives.
• Development of a traceability platform for algae sourcing.

5. Qingdao ZolanBio

Headquarters: Qingdao, China

Key Offering: 10‑20% DHA microcapsule powder for infant formula and nutritional supplements.

Qingdao ZolanBio leverages its vertically integrated algae farm and extraction facility to control quality from seed to powder.

Sustainability & Growth Initiatives: The company has launched a carbon‑neutral production line and is exploring algae‑based bio‑fertilizers.

• Partnership with a major Chinese infant formula OEM.
• Investment in R&D for multi‑layer encapsulation to improve flavor masking.
• Launch of a consumer education campaign highlighting plant‑based DHA benefits.

6. Runke Bio

Headquarters: Guangzhou, China

Key Offering: 10‑20% DHA microcapsule powder for infant nutrition and functional foods.

Runke Bio emphasizes rapid scale‑up and cost efficiency, targeting emerging markets in Southeast Asia and the Middle East.

Sustainability & Growth Initiatives: The company has adopted solar‑powered bioreactors and a water‑recycling protocol.

• Expansion into the Gulf Cooperation Council (GCC) market.
• Launch of a co‑branding program with local nutrition brands.
• Implementation of a real‑time quality monitoring system.

7. FrieslandCampina Ingredients

Headquarters: Delft, Netherlands

Key Offering: DHA microcapsule powder integrated into dairy‑protein systems for infant and adult nutrition.

FrieslandCampina leverages its global protein expertise to embed DHA into protein‑enriched products, expanding the ingredient’s reach beyond pure powder.

Sustainability & Growth Initiatives: The firm is targeting a 30% reduction in water usage across its ingredient plants by 2030.

• Collaboration with dairy brands to develop fortified plant‑based milks.
• Launch of a sustainability dashboard for suppliers.
• Investment in algae‑derived protein research.

8. Progress Biotech

Headquarters: Delft, Netherlands

Key Offering: 10‑20% DHA microcapsule powder with advanced multilayer technology for sensitive applications.

Progress Biotech’s focus on niche markets such as medical nutrition and high‑end infant formula positions it as a trusted partner for premium brands.

Sustainability & Growth Initiatives: The company is piloting algae cultivation on municipal wastewater and has achieved B Corp certification.

• Partnership with a leading pediatric nutrition brand.
• Development of a proprietary encapsulation algorithm to optimize surface oil.
• Launch of a consumer‑facing transparency portal.

9. Algarithm Ingredients

Headquarters: Toronto, Canada

Key Offering: 10‑20% DHA microcapsule powder for functional foods and beverages.

Algarithm focuses on precision formulation, offering customized blends to meet specific nutritional targets.

Sustainability & Growth Initiatives: The firm is implementing a closed‑loop nutrient recycling system and has a carbon offset program.

• Launch of a digital formulation tool for brand partners.
• Collaboration with North American infant formula OEMs.
• Investment in algae strain diversification.

10. MCB Group

Headquarters: Lyon, France

Key Offering: 10‑20% DHA microcapsule powder for infant formula and functional foods.

MCB Group’s strength lies in its robust supply chain and commitment to traceability, ensuring consistent product quality.

Sustainability & Growth Initiatives: The group has committed to achieving net‑zero emissions in its production facilities by 2035.

• Expansion into the European market with a dedicated distribution center.
• Partnership with a leading European infant formula manufacturer.
• Launch of a blockchain‑based traceability platform.

Download FREE Sample Report

Get Full Report

Outlook

Looking ahead, the DHA algae oil microcapsule powder market is set to consolidate around a handful of suppliers that combine technological sophistication with supply‑chain resilience. Manufacturers that demonstrate lower surface‑oil content, rapid delivery, and data‑driven formulation support will command premium pricing, while cost‑efficient producers will capture growth in price‑sensitive emerging markets.

Future Trends

• Personalized nutrition platforms that deliver DHA‑enriched sachets tailored to individual health goals.
• Integration of microencapsulated DHA into plant‑based protein matrices for fortified foods.
• Development of heat‑stable blends for baked goods and confectionery.
• Increased consumer education on algae‑derived sustainability benefits, driving brand loyalty.
• Adoption of digital supply‑chain tools to ensure traceability and compliance with evolving regulations.